These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32295876)
21. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice. Chen YG; Scheuplein F; Driver JP; Hewes AA; Reifsnyder PC; Leiter EH; Serreze DV J Immunol; 2011 Apr; 186(7):4278-84. PubMed ID: 21357538 [TBL] [Abstract][Full Text] [Related]
22. Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand. Kang SW; Lee SC; Park SH; Kim J; Kim HH; Lee HW; Seo SK; Kwon BS; Cho HR; Kwon B Cancer Res; 2017 Nov; 77(21):5989-6000. PubMed ID: 28923858 [TBL] [Abstract][Full Text] [Related]
23. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells. Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662 [TBL] [Abstract][Full Text] [Related]
24. 4-1BB ligand signaling to T cells limits T cell activation. Eun SY; Lee SW; Xu Y; Croft M J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362 [TBL] [Abstract][Full Text] [Related]
25. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337 [TBL] [Abstract][Full Text] [Related]
26. CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages. Xu Y; Yan Y; Geng T; Wang C; Xu Y; Yang P; Yan J J Cardiovasc Pharmacol; 2020 Feb; 75(2):148-154. PubMed ID: 31651672 [TBL] [Abstract][Full Text] [Related]
27. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells. Baessler T; Charton JE; Schmiedel BJ; Grünebach F; Krusch M; Wacker A; Rammensee HG; Salih HR Blood; 2010 Apr; 115(15):3058-69. PubMed ID: 20008791 [TBL] [Abstract][Full Text] [Related]
28. Analysis of CD137 and CD137L expression in human primary tumor tissues. Wang Q; Zhang P; Zhang Q; Wang X; Li J; Ma C; Sun W; Zhang L Croat Med J; 2008 Apr; 49(2):192-200. PubMed ID: 18461674 [TBL] [Abstract][Full Text] [Related]
29. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice. Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784 [TBL] [Abstract][Full Text] [Related]
30. Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. Irie J; Wu Y; Kachapati K; Mittler RS; Ridgway WM Diabetes; 2007 Jan; 56(1):186-96. PubMed ID: 17192481 [TBL] [Abstract][Full Text] [Related]
31. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice. Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408 [TBL] [Abstract][Full Text] [Related]
32. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice. Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102 [TBL] [Abstract][Full Text] [Related]
33. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice. Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669 [TBL] [Abstract][Full Text] [Related]
34. Identification of CD137- and CD137L-Expressing Cells in EL-4 Tumor. Kang SW; Cho HR; Kwon B Methods Mol Biol; 2021; 2248():221-229. PubMed ID: 33185879 [TBL] [Abstract][Full Text] [Related]
35. Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy. Itoh A; Ortiz L; Kachapati K; Wu Y; Adams D; Bednar K; Mukherjee S; Chougnet C; Mittler RS; Chen YG; Dolan L; Ridgway WM Front Immunol; 2019; 10():2566. PubMed ID: 31787971 [TBL] [Abstract][Full Text] [Related]
36. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice. Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715 [TBL] [Abstract][Full Text] [Related]
37. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. Brode S; Raine T; Zaccone P; Cooke A J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572 [TBL] [Abstract][Full Text] [Related]
38. CD137 Ligand-CD137 Interaction is Required For Inflammasome-Associated Brain Injury Following Ischemic Stroke. Fann DY; Nickles EP; Poh L; Rajeev V; Selvaraji S; Schwarz H; Arumugam TV Neuromolecular Med; 2020 Dec; 22(4):474-483. PubMed ID: 33073305 [TBL] [Abstract][Full Text] [Related]
39. High Thymic Output of Effector CD4 Zhao Y; Alard P; Kosiewicz MM J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853 [TBL] [Abstract][Full Text] [Related]
40. [Impact of CD137-CD137L signaling on secretion of mouse vascular smooth muscle cells-derived exosomes: role of Rab7 pathway]. He Y; Cui XG; Li B; Wang N; Xu Y; Xu Y; Geng TX; Yan JC Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):829-835. PubMed ID: 31648466 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]